0001415889-24-008783.txt : 20240320
0001415889-24-008783.hdr.sgml : 20240320
20240320194113
ACCESSION NUMBER: 0001415889-24-008783
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240320
DATE AS OF CHANGE: 20240320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bach Mark Allen
CENTRAL INDEX KEY: 0001962610
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41608
FILM NUMBER: 24769068
MAIL ADDRESS:
STREET 1: C/O STRUCTURE THERAPEUTICS INC.
STREET 2: 611 GATEWAY BLVD, SUITE 223
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Structure Therapeutics Inc.
CENTRAL INDEX KEY: 0001888886
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 981480821
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD SUITE 223
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (628) 229-9277
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD SUITE 223
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: ShouTi Inc.
DATE OF NAME CHANGE: 20211019
4/A
1
form4a-03202024_110306.xml
X0508
4/A
2024-03-15
2024-03-19
0001888886
Structure Therapeutics Inc.
GPCR
0001962610
Bach Mark Allen
C/O STRUCTURE THERAPEUTICS INC.
601 GATEWAY BLVD., SUITE 900
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
CHIEF MEDICAL OFFICER
0
Stock Option (right to buy)
11.75
2024-03-15
4
A
0
65352
0
A
2034-03-14
Ordinary Shares
65352
65352
D
This amendment is being filed to correct the exercise price as that of the Ordinary Shares rather than the American Depositary Shares ("ADSs"). The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.
1/4th of the shares subject to the option shall vest March 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.
The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.
/s/ Jun Yoon, Attorney-in-Fact
2024-03-20